Patrick Lin - 27 Jan 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
27 Jan 2025
Net transactions value
+$34,691
Form type
4
Filing time
29 Jan 2025, 16:20:23 UTC
Previous filing
02 Aug 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Purchase $34,691 +43,500 $0.7975 43,500 27 Jan 2025 Lin Family Trust Feb 4, 2024
holding PCSA Common Stock 29,059 27 Jan 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.